Join us on March 7 for our Educated Patient Summit on Breast Cancer taking place in Miami, FL! 

To start your customized experience click the start button
Customize ?  
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Lung Cancer

Ryan McDonald
The combination of Keytruda plus chemoradiotherapy induced a ‘promising’ 12-month progression-free survival rate in patients with locally advanced non-small cell lung cancer.
Kristie L. Kahl
The Food and Drug Administration granted a priority review to the new drug application for lurbinectedin to treat patients with small cell lung cancer.
Conor Killmurray
The Food and Drug Administration granted a final approval to pemfexy, a branded alternative chemotherapy injection for patients with advanced or metastatic nonsquamous non-small cell lung cancer, potentially offering them a cheaper treatment option in the future.
Beth Fand Incollingo
By taking part in a new survey series, patients with lung cancer can shed light on their quality of life and help drive research.
Conor Killmurray
From thousands of patients with breast cancer told to be re-checked after a surgeon performed botched surgeries to three young brothers receiving the same eye cancer diagnosis, here’s what is making headlines in the cancer space this week.
Conor Killmurray
The Food and Drug Administration approved chemotherapy injection Pemfexy for the treatment of patients with nonsquamous non-small cell lung cancer.
Conor Killmurray
From actress Shannen Doherty announcing she will continue to fight her stage 4 breast cancer to the Food and Drug Administration’s first hearing on asbestos testing in talc in 50 years, here’s what is making headlines in the cancer space this week.
Brielle Benyon
Disparities exist around the globe when it comes to understanding cancer risk factors and prevention measures.
Kristie L. Kahl
In a first-of-its-kind analysis, researchers found that high body mass index may be associated with improved survival in Tecentriq-treated patients with advanced non–small cell lung cancer.

Sign In

Not a member? Sign up now!
Continue without login